(Q35747090)

10 August 2017

title

Tazarotene: therapeutic strategies in the treatment of psoriasis, acne and photoaging (English)

1 reference

10 August 2017

Roeder A

1

1 reference

10 August 2017

Schaller M

series ordinal

2

1 reference

10 August 2017

Schäfer-Korting M

series ordinal

3

1 reference

10 August 2017

Korting HC

series ordinal

4

1 reference

10 August 2017

publication date

1 May 2004

1 reference

Skin Pharmacology and Physiology

10 August 2017

published in

1 reference

10 August 2017

volume

17

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

111-118

1 reference

Vitamin A, differentiation and cancer

10 August 2017

cites work

1 reference

Pharmacokinetics and safety of tazarotene

21 January 2018

1 reference

Recent developments in receptor-selective retinoids

21 January 2018

1 reference

Separation of transactivation and AP1 antagonism functions of retinoic acid receptor alpha

21 January 2018

1 reference

A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors

21 January 2018

1 reference

Up-regulation of elafin/SKALP gene expression in psoriatic epidermis

21 January 2018

1 reference

A pilot study to determine the effect of tazarotene gel 0.1% on steroid-induced epidermal atrophy

21 January 2018

1 reference

Duration of improvement in psoriasis after treatment with tazarotene 0.1% gel plus clobetasol propionate 0.05% ointment: comparison of maintenance treatments

21 January 2018

1 reference

Investigator-masked comparison of tazarotene gel q.d. plus mometasone furoate cream q.d. vs. mometasone furoate cream b.i.d. in the treatment of plaque psoriasis

21 January 2018

1 reference

Combination treatment of psoriasis with photochemotherapy and tazarotene gel, a receptor-selective topical retinoid.

21 January 2018

1 reference

Tazarotene plus UVB phototherapy in the treatment of psoriasis

21 January 2018

1 reference

A comparison of psoralen plus ultraviolet A (PUVA) monotherapy, tacalcitol plus PUVA and tazarotene plus PUVA in patients with chronic plaque-type psoriasis

21 January 2018

1 reference

New understandings of the pathogenesis of acne

21 January 2018

1 reference

A comparison of the efficacy and safety of adapalene gel 0.1% and tretinoin gel 0.025% in the treatment of acne vulgaris: a multicenter trial.

21 January 2018

1 reference

Comparison of adapalene 0.1% solution and tretinoin 0.025% gel in the topical treatment of acne vulgaris.

21 January 2018

1 reference

A multicentre, single-blind, randomized comparison of a fixed clindamycin phosphate/tretinoin gel formulation (Velac) applied once daily and a clindamycin lotion formulation (Dalacin T) applied twice daily in the topical treatment of acne vulgaris

21 January 2018

1 reference

Fifty years of skin aging

21 January 2018

1 reference

Questionable techniques for evaluating photodamage

21 January 2018

1 reference

Efficacy of 0.1% tazarotene cream for the treatment of photodamage: a 12-month multicenter, randomized trial.

21 January 2018

1 reference

Molecular basis of sun-induced premature skin ageing and retinoid antagonism.

21 January 2018

1 reference

Effect of topical retinoic acids on the levels of collagen mRNA during the repair of UVB-induced dermal damage in the hairless mouse and the possible role of TGF-beta as a mediator

21 January 2018

1 reference

Treatment of occupational koilonychia with tazarotene gel.

21 January 2018

1 reference

Type I lamellar ichthyosis improved by tazarotene 0.1% gel.

21 January 2018

1 reference

Confluent and reticulated papillomatosis: Response to tazarotene

21 January 2018

1 reference

Successful treatment of acne vulgaris using a new method: results of a randomized vehicle-controlled trial of short-contact therapy with 0.1% tazarotene gel.

21 January 2018

1 reference

Short-contact therapy with tazarotene in psoriasis vulgaris

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000077236

1 reference

10 August 2017

1 reference